首页> 外文期刊>Open Access Library Journal >A Search for Factors that Predict the Efficacy of Viscosupplementation in Knee Osteoarthritis
【24h】

A Search for Factors that Predict the Efficacy of Viscosupplementation in Knee Osteoarthritis

机译:寻找可预测膝关节骨关节炎中粘稠补充功效的因素

获取原文
       

摘要

Objective: Previous research demonstrates inconsistent effects of hyaluronate (HA) viscosupplementation on patients with knee osteoarthritis (OA). The purpose of this study was to evaluate factors that predict clinical response to a single intra-articular injection of Hylan GF-20. Methods: This was an observational study of 55 patients with knee OA, scheduled to receive intra-articular injections of Hylan GF-20. These patients met the institution’s guidelines for use of viscosupplementation, which entails failure/intolerance of medical management of OA. At baseline, patients completed a series of questionnaires, including the Knee Injury and Osteoarthritis Outcome Score (KOOS) and Patient Health Questionnaire (PHQ-9) depression score. Questionnaires were repeated at three months post-injection. A clinical responder was someone with a change in KOOS score which exceeded the mean minimal detectable change (MDC) values calculated based on test-retest reliability coefficients reported in four prior studies. Hypothesized predictors of response included PHQ-9 score, baseline visual analog scale (VAS) pain score, age, body mass index (BMI), and Kellgren score. Results: There were 35 responders and 20 non-responders. There were no statistically significant differences between responders and non-responders for any of the primary predictors. There were no differences for secondary predictors, including history of knee injury or smoking, prior HA injection, prior intra-articular corticosteroid injection, or location of OA. There was a moderate negative correlation between age and change in total KOOS score (r = —0.32, p = 0.01). Conclusions: Our research did not confirm previous predictors of response to hyaluronate injections, and highlighted the need for prospective studies in order to answer this question.
机译:目的:先前的研究表明透明质酸(HA)粘液补充剂对膝骨关节炎(OA)患者的作用不一致。这项研究的目的是评估预测对单一关节内注射Hylan GF-20的临床反应的因素。方法:这是一项对55例膝OA的观察性研究,预定接受关节内注射Hylan GF-20。这些患者符合该机构关于使用粘膜补充剂的指南,该指南要求对OA进行医疗管理会失败/无法忍受。在基线时,患者完成了一系列问卷调查,包括膝关节损伤和骨关节炎结果评分(KOOS)和患者健康问卷(PHQ-9)抑郁评分。注射后三个月重复问卷调查。临床反应者是KOOS得分变化超过根据四个先前研究报告的重测信度系数计算出的平均最小可检测变化(MDC)值的人。假设的反应预测因子包括PHQ-9评分,基线视觉模拟量表(VAS)疼痛评分,年龄,体重指数(BMI)和Kellgren评分。结果:有35名响应者和20名无响应者。对于任何主要预测因素,应答者和非应答者之间均无统计学上的显着差异。次要预测因素没有差异,包括膝关节损伤或吸烟史,注射HA前,注射关节内皮质类固醇前或OA位置。年龄与总KOOS评分变化之间存在中等程度的负相关(r = -0.32,p = 0.01)。结论:我们的研究并未证实以前对透明质酸盐注射液反应的预测因素,并强调需要进行前瞻性研究以回答这一问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号